About 100 reports

The company' s biosciences division deals with fluorescence-activated cell sorters and analyzers, monoclonal antibodies and kits for performing cell analysis, and molecular indexing for genomics research.

  • Cardiology
  • United States
  • Abbott Laboratories, Inc.
  • Becton, Dickinson and Company, Ltd
  • Boston Scientific Corporation

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Trade

Sanofi' s Praluent was also approved in 2015, and is a monoclonal antibody (mAb) antidyslipidemic with high revenue potential.

  • Cardiology
  • Market Size
  • Merck & Co., Inc.
  • Novartis AG
  • Sanofi S.A.

Monoclonal antibodies such as mepolizumab and omalizumab are sometimes effective.

  • Cardiology
  • Cough And Cold
  • China
  • Demand
  • Market Size
  • Nov 20, 2012: XBiotech Reports Positive Phase II Interim Analysis Results Of MABp1 In Vascular Disease

CV-##C## is based on true human anti-IL-## alpha monoclonal antibody (MABp##) platform technology.

  • Cardiology
  • United States
  • World
  • Product Initiative
  • XBiotech Inc.

Pasteur Institute NA NA MONOCLONAL ANTIBODY TO ANTAGONIZE FCGRIIA FOR AUTOIMMUNE ARTHRITIS, PULMONARY INFLAMMATION, SYSTEMIC ANAPHYLAXIS AND THROMBOCYTOPENIA - DRUG PROFILE Drug Name Company/ Institute Name Licensed From Company Development Partner Product Description

  • Cardiology
  • Cough And Cold
  • United States
  • World
  • Product Initiative
  • Other Developmental Activities
  • Mar 15, 2019: Praluent (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease

IT IS A MONOCLONAL ANTIBODY.

  • Cardiology
  • Cardiovascular Disease
  • Cough And Cold
  • Therapy
  • Esperion Therapeutics, Inc.

Avidity' s platform seeks to combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to potentially overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

  • Cardiology
  • Dermatology
  • World
  • Company
  • Deals & Alliance

Under the terms of consideration, AstraZeneca gains option rights to IPH##, an antibody targeting CD## monoclonal antibody, as well as four pre-clinical molecules from Innate.

  • Cardiology
  • Neurology
  • World
  • Deals & Alliance
  • AstraZeneca PLC

Under the terms of consideration, AstraZeneca gains option rights to IPH##, an antibody targeting CD## monoclonal antibody, as well as four pre-clinical molecules from Innate.

  • Cardiology
  • Endocrine Disease
  • World
  • Company
  • Deals & Alliance

Most recently she served as the Worldwide Brand Director at Novartis Pharmaceuticals Corporation, where she was the global launch lead for Aimovig®, the first monoclonal antibody approved by the U. S.

  • Cardiology
  • Cough And Cold
  • HIV AIDS
  • United States
  • AcelRx Pharmaceuticals, Inc.

The drug candidate is a monoclonal antibody that inhibits binding of IL-## to the ST## receptor.

  • Cardiology
  • Cough And Cold
  • Therapy
  • United States
  • Product Initiative

The prominent features of this report are - ##.

  • Cardiology
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative

Cellmid develops CAB##, a humanized monoclonal antibody for use in solid tumors; CAB##, a monoclonal antibody for the treatment of kidney injury, and inflammatory and fibrotic diseases; and CMK##, a recombinant human form of MK protein for use in cardiac ischem

  • Cardiology
  • Cardiovascular Disease
  • United States
  • Product Initiative
  • Lixte Biotechnology Holdings, Inc.

The prominent features of this report are - ##.

  • Cardiology
  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • World

The two NBE' s are humanized monoclonal therapeutic antibodies.

  • Cardiology
  • Cough And Cold
  • Healthcare
  • Pharmaceutical
  • Glenmark Pharmaceuticals Ltd.

It also develops a product candidate, an anti-CD## monoclonal antibody that inhibits the production of adenosine produced by the tumor cells.

  • Cardiology
  • Cough And Cold
  • Pharmaceutical
  • United States
  • Vernalis plc

The prominent features of this report are - ##.

  • Cardiology
  • Cardiovascular Disease
  • Therapy
  • World
  • Product Initiative

The Impact of Antirheumatic Treatment on Antibody Response and Protection of Infections (Vaccimil) Vaccination in Inflammatory Rheumatic Disease (VACCIMIL).

  • Cardiology
  • Clinical Trial
  • Drug Development
  • Medical Biotechnology
  • World

The Impact of Antirheumatic Treatment on Antibody Response and Protection of Infections (Vaccimil) Vaccination in Inflammatory Rheumatic Disease (VACCIMIL).

  • Cardiology
  • Clinical Trial
  • Medical Biotechnology
  • Therapy
  • World

The two NBE' s are humanized monoclonal therapeutic antibodies.

  • Cardiology
  • Cough And Cold
  • Healthcare
  • Pharmaceutical
  • Glenmark Pharmaceuticals Ltd.

Cemiplimab is an investigational human, monoclonal antibody targeting PD-##, being jointly developed by Sanofi and Regeneron.

  • Cardiology
  • Catheter
  • Cough And Cold
  • France
  • Sanofi S.A.

CEMIPLIMAB IS AN INVESTIGATIONAL HUMAN, MONOCLONAL ANTIBODY TARGETING PD-##, BEING JOINTLY DEVELOPED BY SANOFI AND REGENERON.

  • Cardiology
  • Cough And Cold
  • Southern Europe
  • Western Europe
  • Market Size

It develops new monoclonal antibodies that targets receptors and pathways in controlling the activation of innate immunity cells.

  • Cardiology
  • Cough And Cold
  • United States
  • Company
  • Novo Nordisk Group

The segment' s major product lines include monoclonal antibodies and kits for performing cell analysis, fluorescence-activated cell sorters and analyzers, reagent systems for life science research, diagnostic assays, cell imaging systems, and cell culture media supplements for

  • Cardiology
  • APAC
  • Cardiac and Vascular Group
  • GE Healthcare Limited
  • Medtronic, Inc.

## ## Stemedica Cell Technologies Inc Mochida Pharmaceutical Co Ltd Miragen Therapeutics Inc Medtronic Plc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## GlaxoSmithKline Plc ## ## ## ## ## CryoPort Inc Capricor Therapeutics

  • Cardiology
  • Cardiovascular Disease
  • Therapy
  • World
  • Product Initiative

The company develops therapeutic proteins, monoclonal antibodies and other next-generation molecules targeting various diseases.

  • Cardiology
  • Cough And Cold
  • United States
  • Company
  • Regeneron Pharmaceuticals, Inc.

The company has two preclinical programs, SIRPaFc and a CD## monoclonal antibody (mAb).

  • Cardiology
  • Pharmaceutical
  • United States
  • Company
  • Biogen Idec Inc.

This investigational drug is an immune-optimized, anti-B##-H## monoclonal antibody that incorporates MacroGenics' proprietary Fc Optimization technology platform.

  • Cardiology
  • Ophthalmology
  • World
  • Company
  • Deals & Alliance
  • DIAGNOSTIC ASSAY - CARDIOVASCULAR DISEASES - PRODUCT DESCRIPTION

It is designed to identify the monoclonal antibodies specific to unstable angina in patient' s blood sample.

  • Cardiology
  • Clinical Trial
  • Healthcare
  • United States
  • Pfizer Inc.